NRG Oncology has pulled together a webpage to collate COVID-19 information for patients as well as for our researchers and research staff at our sites.
The NRG Oncology Biospecimen Bank is located in Columbus, Pittsburgh, Houston, and San Francisco.
The NRG Oncology Biospecimen Bank (NRG-BB) is the central repository of biospecimens collected from patients enrolled in NRG Oncology clinical trials. Biospecimens are stored at NRG-BB locations based on disease site. More than 1.5 million biospecimens from more than 519,500 clinical trial cases are stored at the NRG Biospecimen Bank. These include unstained slides, tissue blocks, frozen and fresh tissues, and fluids, such as plasma or serum, from various disease sites. Extensive concomitant clinical follow-up data on the patients is managed by the NRG Oncology Statistics and Data Management Center.
The purpose of the NRG-BB is to store and distribute biospecimens. The NRG-BB is the primary provider of protocol-based kits for sites to collect, process and ship patient biospecimens to the NRG-BB.
The NRG-BB also provides annotated patient samples to qualified investigators who have significant research hypotheses that merit the use of such specimens. Investigators interested in using specimens from the NRG-BB can obtain information and application forms at: https://www.nrgoncology.org/Scientific-Program/Biospecimen-Access
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.